Tumor Necrosis Factor
OtherThis study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
NCT Number: NCT06523075
The aim of this study is to identify risk factors associated with sepsis and to construct a predictive model for sepsis. This will provide an objective theoretical and empirical foundation for the diagnosis, assessment, and management of sepsis in our country.The primary questions addressed are:
What are the risk factors for the development of sepsis? How do we improve the prognosis of sepsis?
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,, Wenzhou, Zhejiang, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.
Time frame: 3 months
A rapid increase of 2 or more points points in the Sequential Organ Failure Assessment (SOFA) score after patient infection.SOFA score, which ranges from a minimum of 2 to a maximum of 15, indicates a worse outcome with higher scores.
Second Affiliated Hospital of Wenzhou Medical University
Other
Construction and Validation of a Sepsis Prediction Model Based on Dysregulation of Host Response
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06541600
Infections, Inflammation
Wuhan, Hubei, China
View Trial DetailsNCT06080282
Infections, Inflammation
Wuhan, Hubei, China
View Trial DetailsNCT07025096
Acute Respiratory Distress Syndrome (ARDS), Infections
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06876168
Acute Respiratory Failure, Infections
Lexington, Kentucky, United States
View Trial Details